Comment from Wave Life Sciences

Summary: Wave Life Sciences, a biotechnology company, supports the proposed AI-enabled optimization of early-phase clinical trials pilot program as a way to ensure the technology is thoughtfully controlled. They provide specific recommendations on trial scope, participant selection (particularly for smaller sponsors), infrastructure requirements like secure sandboxes, and safety oversight.